SCM

Segantii Capital Management Portfolio holdings

AUM $1.02B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+16.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.73B
AUM Growth
-$933M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
200
New
Increased
Reduced
Closed

Top Buys

1 +$111M
2 +$51.5M
3 +$48M
4
AMED
Amedisys
AMED
+$32.2M
5
ACI icon
Albertsons Companies
ACI
+$17.5M

Top Sells

1 +$1.29B
2 +$90.4M
3 +$37.4M
4
ABCM
Abcam PLC
ABCM
+$34.5M
5
BHC icon
Bausch Health
BHC
+$24.7M

Sector Composition

1 Consumer Discretionary 19.49%
2 Healthcare 13.48%
3 Energy 6.68%
4 Consumer Staples 6.55%
5 Materials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSI.WS
101
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$80.4K ﹤0.01%
7,785
HASI icon
102
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.69B
$77.2K ﹤0.01%
+2,800
CEROW
103
DELISTED
CERo Therapeutics Warrants
CEROW
$55K ﹤0.01%
5,000
AERTW
104
Aeries Technology Warrant
AERTW
$954K
-25,000
ARM icon
105
Arm
ARM
$128B
-99,620
ARRY icon
106
Array Technologies
ARRY
$1.09B
-49,000
AWK icon
107
American Water Works
AWK
$26.4B
-13,100
BEPC icon
108
Brookfield Renewable
BEPC
$7.22B
-20,000
BHC icon
109
Bausch Health
BHC
$2.06B
-3,000,000
BLCO icon
110
Bausch + Lomb
BLCO
$6.23B
-500,000
CNMD icon
111
CONMED
CNMD
$1.28B
-36,900
COTY icon
112
Coty
COTY
$2.1B
-918,575
CUK icon
113
Carnival PLC
CUK
$35.6B
-158,000
FRO icon
114
Frontline
FRO
$7.77B
-145,247
GLD icon
115
SPDR Gold Trust
GLD
$179B
0
HDB icon
116
HDFC Bank
HDB
$156B
-1,272,400
ILCV icon
117
iShares Morningstar Value ETF
ILCV
$1.2B
0
JAZZ icon
118
Jazz Pharmaceuticals
JAZZ
$11.3B
-25,300
JBLU icon
119
JetBlue
JBLU
$1.68B
0
LCID icon
120
Lucid Motors
LCID
$3.21B
0
LLY icon
121
Eli Lilly
LLY
$878B
-5,000
MARA icon
122
Marathon Digital Holdings
MARA
$3.32B
-18,400
NCLH icon
123
Norwegian Cruise Line
NCLH
$9.53B
-96,000
NTNX icon
124
Nutanix
NTNX
$10.9B
-76,600
NVO icon
125
Novo Nordisk
NVO
$174B
-75,000